Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,850 | -25,690 | -20,340 | -15,220 | -4,830 |
| Depreciation Amortization | 390 | 1,700 | 1,300 | 870 | 430 |
| Other Working Capital | -700 | -11,520 | -7,870 | 730 | -1,710 |
| Other Operating Activity | 360 | 4,390 | 3,500 | -1,210 | -670 |
| Operating Cash Flow | $-5,800 | $-31,120 | $-23,410 | $-14,830 | $-6,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -840 | -710 | -590 | -150 |
| Other Investing Activity | 0 | -1,200 | -1,000 | -1,000 | 0 |
| Investing Cash Flow | $0 | $-2,040 | $-1,710 | $-1,590 | $-150 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -10 | 9,570 | 9,580 | 20 | 10 |
| Financing Cash Flow | $-10 | $9,570 | $9,580 | $20 | $10 |
| Beginning Cash Position | 8,910 | 32,500 | 32,500 | 32,500 | 32,500 |
| End Cash Position | 3,090 | 8,910 | 16,960 | 16,090 | 25,580 |
| Net Cash Flow | $-5,820 | $-23,590 | $-15,540 | $-16,410 | $-6,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,800 | -31,120 | -23,410 | -14,830 | -6,780 |
| Free Cash Flow | -5,800 | -31,120 | -23,410 | -14,830 | -6,780 |